|
Tofler, Geoffrey H; Massaro, Joseph; Levy, Daniel A et al. (2017) Increased heart rate is associated with a prothrombotic state: The Framingham Heart Study. Eur J Prev Cardiol 24:382-388
|
|
Brody, Jennifer A; Morrison, Alanna C; Bis, Joshua C et al. (2017) Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology. Nat Genet 49:1560-1563
|
|
Puurunen, Marja K; Hwang, Shih-Jen; O'Donnell, Chris J et al. (2017) Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study. Thromb Res 151:57-62
|
|
Tofler, G H; Massaro, J; O'Donnell, C J et al. (2016) Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study. Thromb Res 140:30-35
|
|
Sloan, Arielle; Gona, Philimon; Johnson, Andrew D (2015) Cardiovascular correlates of platelet count and volume in the Framingham Heart Study. Ann Epidemiol 25:492-8
|
|
Faraday, Nauder; Yanek, Lisa R; Yang, Xiao Ping et al. (2011) Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood 118:3367-75
|
|
Johnson, Andrew D; Yanek, Lisa R; Chen, Ming-Huei et al. (2010) Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 42:608-13
|
|
Wang, Thomas J; Gona, Philimon; Larson, Martin G et al. (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355:2631-9
|
|
Meigs, James B; Dupuis, Josee; Liu, Chunyu et al. (2006) PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample. Obesity (Silver Spring) 14:753-8
|
|
Meigs, James B; O'donnell, Christopher J; Tofler, Geoffrey H et al. (2006) Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55:530-7
|
Showing the most recent 10 out of 22 publications
